Search
for
Sort by
Research 61–90 of 73
- Frontiers in alopecia areata pathobiology research
- Recent Advances in the Structural Design of Photosensitive Agent Formulations Using “Soft” Colloidal Nanocarriers
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- Binding Interactions of Keratin-Based Hair Fiber Extract to Gold, Keratin, and BMP-2
- Phenotypic Analysis of T-Cells in Extensive Alopecia Areata Scalp Suggests Partial Tolerance
- SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- UDP-GlcNAc-1-Phosphotransferase Is a Clinically Important Regulator of Human and Mouse Hair Pigmentation
- Recent advances in understanding of radiation-induced skin tissue reactions with respect to acute tissue injury and late adverse effect
- Hairless Descendants of Mexican Hairless Dogs: An Experimental Model for Studying Hypertrophic Scars
- Recent Advances in Biodegradable and Biocompatible Synthetic Polymers Used in Skin Wound Healing
- Stimuli-responsive hydrogels for radiation-induced skin injury: from passive barriers to autonomous drug delivery systems
- Alternative androgen pathways
- Comparing the Efficiency of Elidel Cream and Elidel Accompanied With Tretinoin Cream in Treatment of Alopecia Areata
- Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas
- Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus
- Frontal fibrosing alopecia among men: A clinicopathologic study of 7 cases
- Cutaneous lupus erythematosus: clinico-pathologic correlation
- Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
- The comparison of treatment with clobetasol propionate 0.05% and topical pimecrolimus 1% treatment in the treatment of alopecia areata
- Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Safety of Common Medications for Treating Dermatology Disorders in Pregnant Women
- Dermatological medications and local therapeutics
- [Translated article] Sensitive Scalp: Diagnosis and Practical Management
- Resolution of Discoid Lupus Alopecia With Systemic Hydroxychloroquine and Topical Pimecrolimus Combination Therapy
- Therapeutic Updates on Lichen planopilaris and Frontal Fibrosing Alopecia: A Systematic Review
- Frontalna fibrozirajuća alopecija
- Alopesi areata hastalarında topikal kortikosteroid (%0.05 Klobetasol Propionat) tedavisi ile % 1 topikal pimekrolimus tedavisinin karşılaştırılması / Comparison of topical corticosteroid (%0.05 Clobetasol propionate) treatment and %1 pimecrolimus treatment in alopesia areata patients
- What's New: Newly Approved Drugs for Children